Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Hydroxycarbamide

Brand: 
NICE TA: 
Indication: Treatment of essential thrombocythemia or polycythaemia vera with a high risk for thromboembolic complications
Disease category: Immune system and Malignant Disease
Commissioning responsibility: CCG
PbR excluded: No

Background

It was decided at the July meeting of the LMMG that the indications that were previously considered for shared care in Lancashire would be retained in secondary care. This applies in all Lancashire CCGs except Morecambe Bay where existing shared care arrangements are in place and should continue to be followed.

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

None

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red